RAREUltragenyx Pharmaceutical Inc.

$26.47

Who owns RARE

291 institutions reported holding RARE for 2026Q1, together 97% of the company, more than the 281 a quarter earlier.

291

Institutions reporting a position · as of 2026Q1 · up from 281 the quarter before

Shares held by institutions
98.1M

Shares held by institutions · 97% of the company · long US equity positions only, as reported on Form 13F

Reported value
$2.05B

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
31%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
49
New positions
56
Positions exited
52
Added to
121
Reduced
77
Top 10 holdersof the company
44%
Institutional ownership by quarter, 2014Q1 to 2026Q1
QuarterFilersSharesReported value
2026Q129198.1M$2.05B
2025Q428193.9M$2.16B
2025Q329795.4M$2.87B
2025Q230594.1M$3.42B
2025Q129489.8M$3.25B
2024Q430987.5M$3.68B
2024Q329686.8M$4.82B
2024Q227388.2M$3.63B
2024Q126779.9M$3.73B
2023Q423380.4M$3.84B
2023Q321770.6M$2.52B
2023Q223969.5M$3.20B
2023Q122468.7M$2.75B
2022Q422568.0M$3.15B
2022Q323167.9M$2.81B
2022Q221967.5M$4.03B
Largest reported holders, 2026Q1
HolderShares% of companyValue
VANGUARD GROUP INC10.3M10%$216M
BlackRock Inc.7.3M7.3%$153M
STATE STREET CORP5.0M5.0%$105M
AQR CAPITAL MANAGEMENT LLC4.6M4.6%$96M
RTW INVESTMENTS, LP3.6M3.6%$76M
SANDS CAPITAL MANAGEMENT, LLC3.2M3.2%$67M
Sofinnova Investments, Inc.3.1M3.1%$66M
WELLINGTON MANAGEMENT GROUP LLP2.6M2.6%$55M
Bellevue Group AG2.4M2.4%$50M
Assenagon Asset Management S.A.2.3M2.2%$47M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…